Selumetinib granules in sprinkle capsules for opening 5 mg ( DrugBank: Selumetinib )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
34	神経線維腫症	1

34. 神経線維腫症

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005608-20-ES (EUCTR)	16/02/2022	19/10/2021	Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children aged = 1 to ...	A Phase I/II, Single-Arm, Open label Study to Evaluate the Pharmacokinetics, Safety/Tolerability and ...	Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN) MedDRA version: 20.0;Level: LLT; ...	Product Name: Selumetinib granules in sprinkle capsules for opening 5 mg Product Code: AZD6244 INN or ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	38	Phase 1;Phase 2	United States;Spain;Russian Federation;Netherlands;Germany;Italy

First Previous1Next Last